Back to search
Severe Non-proliferative Diabetic Retinopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Severe Non-proliferative Diabetic Retinopathy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Severe Non-proliferative Diabetic Retinopathy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study.…
The objective of this study is to evaluate the safety and efficacy of APX3330 to treat diabetic retinopathy (DR) and diabetic macular edema (DME).